Cardiovascular Endocrinology and Lipid Metabolism

Effect of testosterone on hepatic liver X receptor and ApoE expression as a potential mechanism of atheroprotection in the testicular feminised mouse

ea0029p271 | Cardiovascular Endocrinology and Lipid Metabolism

The effect of potassium supplementation on the endothelium, the renin-angiotensin-aldosterone system (RAAS) and blood pressure in patients at moderate cardiovascular disease risk

ea0029p272 | Cardiovascular Endocrinology and Lipid Metabolism

(Pro)renin Receptor is essential for filtration barrier in glomerular podocyte

ea0029p273 | Cardiovascular Endocrinology and Lipid Metabolism

Testosterone replacement therapy: a safety audit of clinical practice including men with Type 2 diabetes and cardiovascular disease

ea0029p274 | Cardiovascular Endocrinology and Lipid Metabolism

Thyroid axis hormones and cortisol are associated with subjective fatigue in patients with coronary artery disease

ea0029p275 | Cardiovascular Endocrinology and Lipid Metabolism

Familiar hypercholesterolemia: effects of treatment with rosuvastin

ea0029p276 | Cardiovascular Endocrinology and Lipid Metabolism

Metabolic and glycaemic profile in patients with acute coronary syndrome

ea0029p277 | Cardiovascular Endocrinology and Lipid Metabolism

Impact of 6-month course of 1 mg finasteride tablets on levels of lipid profile in men with androgenic alopecia

ea0029p278 | Cardiovascular Endocrinology and Lipid Metabolism

Transient glucocorticoid excess does not cause persisting metabolic changes in mice

ea0029p279 | Cardiovascular Endocrinology and Lipid Metabolism

Gastrectomy for early gastric cancer is associated with decreased cardiovascular mortality in accordance with amelioration of metabolic abnormalities, visceral adiposity and atherosclerosis

ea0029p280 | Cardiovascular Endocrinology and Lipid Metabolism

The role of testosterone activation of liver X receptor in a human macrophage cell line and its implications for the treatment of type 2 diabetes and atherosclerosis

ea0029p281 | Cardiovascular Endocrinology and Lipid Metabolism

Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human coronary arterial wall and pericoronary adipose tissue in correlation with atherosclerosis

ea0029p282 | Cardiovascular Endocrinology and Lipid Metabolism

Six loci associated with high-density lipoprotein cholesterol or triglycerides in Chinese pregnant women

ea0029p283 | Cardiovascular Endocrinology and Lipid Metabolism

Development of primary hyperparathyroidism is closely associated with the onset of dyslipidemia and insulin resistance in a large family harboring a MEN1 gene mutation

ea0029p284 | Cardiovascular Endocrinology and Lipid Metabolism

Level of adiponectin and vaspin, and adiponectin/vaspin ratio is associated with insulin resistance and clinical expression of metabolic syndrome in type 2 diabetic patients

ea0029p285 | Cardiovascular Endocrinology and Lipid Metabolism

Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial

ea0029p286 | Cardiovascular Endocrinology and Lipid Metabolism

The role of β-arrestin proteins in CB1 cannabinoid receptor endocytosis

ea0029p287 | Cardiovascular Endocrinology and Lipid Metabolism

Abstract unavailable

ea0029p288 | Cardiovascular Endocrinology and Lipid Metabolism

Plasma aldosterone to plasma renin ratio on an automated analyzer using two novel chemiluminescence immunoassays

ea0029p289 | Cardiovascular Endocrinology and Lipid Metabolism

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

ea0029p290 | Cardiovascular Endocrinology and Lipid Metabolism

Testosterone and cardiovascular risk in patients with erectile dysfunction

ea0029p291 | Cardiovascular Endocrinology and Lipid Metabolism

Oxytocin stimulates cardiomyogenesis and cardioprotection via stem cells activation

ea0029p292 | Cardiovascular Endocrinology and Lipid Metabolism

Metabolism of angiotensin II and angiotensin III in HAC15 cells

ea0029p293 | Cardiovascular Endocrinology and Lipid Metabolism

Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human aortic wall and periaortic adipose tissue in correlation with atherosclerosis

ea0029p294 | Cardiovascular Endocrinology and Lipid Metabolism

In primary aldosteronism, plasma aldosterone concentration is an independent risk factor for albuminuria, and the higher baseline urinary albumin excretion predicts the less glomerular filtration rate after treatment

ea0029p295 | Cardiovascular Endocrinology and Lipid Metabolism

Relationships between insulin resistance and cardiovascular risk factors in primary hyperparathyroidism

ea0029p296 | Cardiovascular Endocrinology and Lipid Metabolism

Allosteric effects between the protomers of AT1 angiotensin receptor homodimer: role of the conserved DRY motif

ea0029p297 | Cardiovascular Endocrinology and Lipid Metabolism

Effect of triiodothyronine and angiotensin-II on expression of (pro)renin receptor in the human erythroid cell line, YN-1

ea0029p298 | Cardiovascular Endocrinology and Lipid Metabolism

The combined use of serum interleukin 6 and C-reactive protein is better than either alone in predicting cardiovascular events in a Chinese population

ea0029p299 | Cardiovascular Endocrinology and Lipid Metabolism

Short-term detraining cannot reverse insulin sensitivity improvement and serum retinol binding protein 4 in spontaneously hypertensive rats previously submitted to aerobic exercise

ea0029p300 | Cardiovascular Endocrinology and Lipid Metabolism

Multiple cardiovascular risk factors in patients with myotonic dystrophy type 1 and 2

ea0029p301 | Cardiovascular Endocrinology and Lipid Metabolism

Role of peroxisome proliferator-activated receptor-γ (PPARγ) in regulation of glucocorticoid metabolism in vascular smooth muscle cells

ea0029p302 | Cardiovascular Endocrinology and Lipid Metabolism

Recombinant erythropoietin treatment enhances mitochondrial function in human skeletal muscle

ea0029p303 | Cardiovascular Endocrinology and Lipid Metabolism

Association of IL4 receptor gene polymorphisms with high density lipoprotein cholesterol

ea0029p304 | Cardiovascular Endocrinology and Lipid Metabolism

Cardiovascular risk factors in a large cohort of children with GH deficiency

ea0029p305 | Cardiovascular Endocrinology and Lipid Metabolism

Lipid profile in children with persistent idiopathic subclinical hypothyroidism

ea0029p306 | Cardiovascular Endocrinology and Lipid Metabolism

Variants of endothelial nitric oxide synthase gene are associated with components of metabolic syndrome in an Arab population

ea0029p307 | Cardiovascular Endocrinology and Lipid Metabolism

MRTF-A, a rho-dependent co-activator of SRF, regulates phenotypic modulation of vascular smooth muscle cells and plays an important role in vascular remodeling

ea0029p308 | Cardiovascular Endocrinology and Lipid Metabolism

Association of PON-1 activity and other anti-oxidative enzymes with long-chain fatty acids profile in T2DM

ea0029p309 | Cardiovascular Endocrinology and Lipid Metabolism

Risk factors of metabolic syndrome in adolescent with classical congenital adrenal hyperplasia

ea0029p310 | Cardiovascular Endocrinology and Lipid Metabolism

Alterations of protein expression profiles in 3T3-L1 adipocytes by interleukin 4

ea0029p311 | Cardiovascular Endocrinology and Lipid Metabolism

Anti-Müllerian hormone may be a hormonal regulator of the cardiovascular system

ea0029p312 | Cardiovascular Endocrinology and Lipid Metabolism

Anti-oxidataive actions of urocortin on HL-1 cardiomyocytes

ea0029p313 | Cardiovascular Endocrinology and Lipid Metabolism

Adipokine expression profile in pericoronary and periaortic adipose tissue in correlation with coronary and aortic atherosclerosis

ea0029p314 | Cardiovascular Endocrinology and Lipid Metabolism

Fatty liver index and lipid accumulation product index as markers of liver steatosis in premenopausal women with nonalcoholic fatty liver disease

ea0029p315 | Cardiovascular Endocrinology and Lipid Metabolism

Effects of long-term treatment of hypogonadal men with testosterone undecanoate on blood pressure, fasting glucose, HbA1c and C-reactive protein

ea0029p316 | Cardiovascular Endocrinology and Lipid Metabolism

Dysregulation of tissue renin–angiotensin–aldosterone system in obese hypertensive rats

ea0029p317 | Cardiovascular Endocrinology and Lipid Metabolism

The relationship between 25(OH)D levels and markers of atherosclerosis and inflammation in type 2 diabetic patients

ea0029p318 | Cardiovascular Endocrinology and Lipid Metabolism

Plasma total homocysteine levels in transsexuals after cross-sex hormonal treatment

ea0029p319 | Cardiovascular Endocrinology and Lipid Metabolism

Body composition and association to NT-proBNP and myostatin levels in heart failure patients

ea0029p320 | Cardiovascular Endocrinology and Lipid Metabolism

Subclinical atherosclerosis and arterial stiffness are associated with levels of circulating androgens in healthy recently menopausal women

ea0029p321 | Cardiovascular Endocrinology and Lipid Metabolism

Metabolic syndrome, hormone levels and inflammation in patients with erectile dysfunction

ea0029p322 | Cardiovascular Endocrinology and Lipid Metabolism

Duration effect of statin therapy on bone metabolism in dyslipidemic patients

ea0029p323 | Cardiovascular Endocrinology and Lipid Metabolism

Coronary flow reserve is inversely related to urinary cortisol in Cushing’s syndrome

ea0029p324 | Cardiovascular Endocrinology and Lipid Metabolism

Myeloperoxidase is not associated with applications of coronary artery disease and type 2 diabetic patients

ea0029p325 | Cardiovascular Endocrinology and Lipid Metabolism

Analysis of hyponatremia in a tertiary hospital during a 5 year period

ea0029p326 | Cardiovascular Endocrinology and Lipid Metabolism

Effect of melatonin supplementation on lipid peroxidation and on the enzymes of antioxidative system in patients with chronic coronary artery disease.

ea0029p327 | Cardiovascular Endocrinology and Lipid Metabolism

N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with non-ST-elevation myocardial infarction (NSTEMI) compared to patients with unstable angina (UA) in a lot of patients admitted for non-ST-elevation acute coronary syndrome (NSTE-ACS)

ea0029p328 | Cardiovascular Endocrinology and Lipid Metabolism

Sympathetic over-activity and low adrenocortical responses to hypoglycemia in patients in early stage of hypertension

ea0029p333 | Cardiovascular Endocrinology and Lipid Metabolism

The effect of thyroxine replacement on reduction of small dense low-density lipoprotein (sdLDL) in patients with primary hypothyroidism.

ea0029p334 | Cardiovascular Endocrinology and Lipid Metabolism

Metabolic consequences of obesity in children and adolescents

ea0029p335 | Cardiovascular Endocrinology and Lipid Metabolism

Study on the DHEA-S secretion dynamics in elderly pacients with cardiovascular diseases

ea0029p336 | Cardiovascular Endocrinology and Lipid Metabolism

Testosterone and androstane-3α, 17β-diol glucuronide correlate with coronary disease

ea0029p337 | Cardiovascular Endocrinology and Lipid Metabolism

Cardiovascular function and IGF1 deficit (IGF1-D) in β-thalassemia major

ea0029p338 | Cardiovascular Endocrinology and Lipid Metabolism

Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors

ea0029p339 | Cardiovascular Endocrinology and Lipid Metabolism

The importance of HDL cholesterol to predict adiponectin and retinol binding protein 4 concentration after one session resistance exercise

ea0029p340 | Cardiovascular Endocrinology and Lipid Metabolism

Intrinsic myocardial disease in adults with GH deficiency is characterised by subclinical left ventricular longitudinal dysfunction revealed by tissue Doppler

ea0029p341 | Cardiovascular Endocrinology and Lipid Metabolism

Paraoxonase, malondialdehyde and lipids in subjects with asymptomatic gallstones

ea0029p341.1 | Cardiovascular Endocrinology and Lipid Metabolism

15th International & 14th European Congress of Endocrinology

Abstract unavailable

BiosciAbstracts